Valneva SE

LSE:0OB3 Stock Report

Market Cap: €322.5m

Valneva Management

Management criteria checks 1/4

Valneva's CEO is Thomas Lingelbach, appointed in May 2013, has a tenure of 11.58 years. total yearly compensation is €919.56K, comprised of 58.8% salary and 41.2% bonuses, including company stock and options. directly owns 0.24% of the company’s shares, worth €765.70K. The average tenure of the management team and the board of directors is 1 years and 1.8 years respectively.

Key information

Thomas Lingelbach

Chief executive officer

€919.6k

Total compensation

CEO salary percentage58.8%
CEO tenure11.6yrs
CEO ownership0.2%
Management average tenureless than a year
Board average tenure1.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Thomas Lingelbach's remuneration changed compared to Valneva's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-€7m

Jun 30 2024n/an/a

-€32m

Mar 31 2024n/an/a

-€24m

Dec 31 2023€920k€541k

-€101m

Sep 30 2023n/an/a

-€113m

Jun 30 2023n/an/a

-€7m

Mar 31 2023n/an/a

-€135m

Dec 31 2022€784k€525k

-€143m

Sep 30 2022n/an/a

€73m

Jun 30 2022n/an/a

-€159m

Mar 31 2022n/an/a

-€72m

Dec 31 2021€769k€420k

-€73m

Sep 30 2021n/an/a

-€248m

Jun 30 2021n/an/a

-€125m

Mar 31 2021n/an/a

-€91m

Dec 31 2020€649k€376k

-€64m

Sep 30 2020n/an/a

-€62m

Jun 30 2020n/an/a

-€25m

Mar 31 2020n/an/a

-€8m

Dec 31 2019€1m€384k

-€2m

Sep 30 2019n/an/a

€4m

Jun 30 2019n/an/a

€1m

Mar 31 2019n/an/a

€7m

Dec 31 2018€694k€377k

€3m

Sep 30 2018n/an/a

-€7m

Jun 30 2018n/an/a

-€7m

Mar 31 2018n/an/a

-€8m

Dec 31 2017€649k€367k

-€11m

Compensation vs Market: Thomas's total compensation ($USD957.08K) is about average for companies of similar size in the UK market ($USD963.84K).

Compensation vs Earnings: Thomas's compensation has increased whilst the company is unprofitable.

CEO

Thomas Lingelbach (61 yo)

11.6yrs

Tenure

€919,563

Compensation

Mr. Thomas Lingelbach has been the Chief Executive Officer of Valneva SE since May 2013 and served as its Chairman and Member of the Management Board since May 10, 2013 until December 20, 2023 and serves a...

Leadership Team

NamePositionTenureCompensationOwnership
Thomas Lingelbach
President11.6yrs€919.56k0.24%
€ 765.7k
Peter Buhler
Chief Financial Officerno data€558.83k0.028%
€ 88.9k
Franck Grimaud
Chief Business Officerless than a year€401.34k0.39%
€ 1.3m
Juan-Carlos Jaramillo
Chief Medical Officerless than a year€539.76k0.028%
€ 88.9k
Dipal Patel
Chief Commercial Officerless than a year€516.75kno data
Vincent Dequenne
Chief Operating Officerno datano datano data
Hanneke Schuitemaker
Chief Scientific Officerless than a yearno datano data
Joshua Drumm
Vice President of Investor Relations3.4yrsno datano data
Laetitia Bachelot-Fontaine
VP of Global Communications & European Investor Relationsno datano datano data
Petra Pesendorfer
Chief People Officerless than a yearno datano data
Christian Taucher
Head of Global Medical Affairsno datano datano data
Susanne Eder-Lingelbach
Head of Clinical Operationsno datano datano data

1.0yrs

Average Tenure

53yo

Average Age

Experienced Management: 0OB3's management team is not considered experienced ( 1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Thomas Lingelbach
Presidentless than a year€919.56k0.24%
€ 765.7k
James Sulat
Directorless than a year€74.07k0.019%
€ 60.3k
Alexander Von Gabain
Member of Scientific Advisory Board4.9yrs€10.00kno data
James Connolly
Directorless than a year€66.11kno data
Kathrin Jansen
Directorless than a year€28.25kno data
Mailys Ferrere
Directorless than a yearno datano data
George R. Siber
Member of Scientific Advisory Board5.1yrsno datano data
Ralf Leo Clemens
Chair of Scientific Advisory Board5.4yrs€2.92kno data
Norman Baylor
Member of Scientific Advisory Board5.1yrsno datano data
Anne-Marie Graffin
Chairmanless than a year€74.30k0.0088%
€ 28.3k
Thomas Decker
Member of Scientific Advisory Board2.6yrsno datano data
Michael Pfleiderer
Member of Scientific Advisory Board2.6yrsno datano data

1.8yrs

Average Tenure

65yo

Average Age

Experienced Board: 0OB3's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 11:49
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Valneva SE is covered by 25 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stéphan DubosqArkeon Finance
Jean-Jacques Le FurBryan Garnier & Co
Bruno BulicBryan Garnier & Co